Cardiovascular manifestations of sedatives and analgesics in the critical care unit

American Journal of Therapeutics

Volumn 16, Issue 4, 2009, Pages 339-353

  Darrouj, Jamil ^a   Karma, Lama ^a   Arora, Rohit ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Department of Cardiology North Chicago VA ^*  (United States)

Author keywords

And heart failure; Benzodiazepines; Bradycardia; Cardiac side effects; Coronary artery disease; Critical care units; Diazepam; Etomidate; Hypotension; Lorazepam; Midazolam; Morphine; Propofol

Indexed keywords

ANALGESIC AGENT; ARECAIDINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; ETOMIDATE; FLUMAZENIL; GLYCERYL TRINITRATE; HYPERTENSIVE FACTOR; KETAMINE; LIDOCAINE; LORAZEPAM; MIDAZOLAM; MORPHINE; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE; PROPOFOL; SEDATIVE AGENT; THIOPENTAL;

ADRENAL INSUFFICIENCY; ANALGESIA; BLOOD PRESSURE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; HEAD INJURY; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART INFARCTION SIZE; HEART OUTPUT; HEART PROTECTION; HEART RATE; HEMODYNAMICS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; HYPOVOLEMIA; INTENSIVE CARE UNIT; LACTIC ACIDOSIS; LUNG EDEMA; MORTALITY; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SHOCK; SIDE EFFECT; SPINAL ANESTHESIA; ST SEGMENT ELEVATION; STRESS; TACHYCARDIA;

ANALGESICS, OPIOID; ANIMALS; BENZODIAZEPINES; BRADYCARDIA; CORONARY ARTERY DISEASE; CRITICAL ILLNESS; ETOMIDATE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; INTENSIVE CARE UNITS; MORPHINE; PROPOFOL;

EID: 68949186247     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pap.0000249925.76324.47     Document Type: Review

References (222)

1. Gravel NR, Searle NR, Sahab PG, et al. Sedation in critically ill patients: practical recommendations. CNS Drugs. 1999;11:9-22.
2. Chernow B. Hormonal responses to graded surgical stress. Arch Intern Med. 1987;147:1273-1278.
3. Epstein J. The stress response of critical illness. Crit Care Clin. 1999;15:17-33.
4. Chambrier C. Cytokine and hormonal changes after cholecystectomy. Effect of ibuprofen pretreatment. Ann Surg. 1996;224:178-182.
5. Chan V. Pituitary-thyroid responses to surgical stress. Acta Endocrinol (Copenh). 1978;88:490-498.
6. Halter JB. Mechanism of plasma catecholamine increases during surgical stress in man. J Clin Endocrinol Metab. 1977;45:936-944.
7. Merin RG. Effect of anesthetic drugs on myocardial performance in man. Annu Rev Med. 1977;28:75-83.
8. Barak M. Hemodynamic and catecholamine response to tracheal intubation: direct laryngoscopy compared with fiberoptic intubation. J Clin Anesth. 2003;15:132-136.
9. Fujii Y. Circulatory responses to laryngeal mask airway insertion or tracheal intubation in normotensive and hypertensive patients. Can J Anaesth. 1995;42:32-36.
10. McCoy EP. A comparison of the stress response to laryngoscopy. The Macintosh versus the McCoy blade. Anaesthesia. 1995;50:943-946.
11. Finfer SR. Cardiovascular responses to tracheal intubation: a comparison of direct laryngoscopy and fibreoptic intubation. Anaesth Intensive Care. 1989;17:44-48.
12. Pernerstorfer T. Stress response to tracheal intubation: direct laryngoscopy compared with blind oral intubation. Anaesthesia. 1995;50:17-22.
13. Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med. 1990;323:1781-1788.
14. Evseeva ME. Stress-induced rearrangement of the myocardium: time course of structural changes in various types of stress. Bull Exp Biol Med. 2000;130:937-939.
15. Carter JR, Sauder CL, Ray CA. Effect of morphine on sympathetic nerve activity in humans. J Appl Physiol. 2002;93:1764-1769.
16. Kestin I. Morphine. Update in Anesthesia. 1993;3:1.
17. Urthaler F, Isobe JH, James TN. Direct and vagally mediated chronotropic effects of morphine studied by selective perfusion of the sinus node of awake dogs. Chest. 1975;68:222-228.
18. Feldberg W, Wei E. Analysis of cardiovascular effects of morphine in the cat. Neuroscience. 1986;17:495-506.
19. Mori T, Nishikawa K, Terai T, et al. The effects of epidural morphine on cardiac and renal sympathetic nerve activity in alpha-chloralose-anesthetized cats. Anesthesiology. 1998;88:1558-1565.
20. Fahmy NR, Sunder N, Soter NA. Role of histamine in the hemodynamic and plasma catecholamine responses to morphine. Clin Pharmacol Ther. 1983;33:615-620.
21. Philbin DM, Moss J, Akins CW, et al. The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study. Anesthesiology. 1981;55:292-296.
22. Mildh LH, Tuomisto LM, Scheinin M, et al. Morphine-induced cardiovascular stimulation: the effects of two doses on healthy subjects. Anesth Analg. 2000;91:51-57.
23. Fillingim RB, Ness TJ, Glover TL, et al. Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J. Pain. 2005;6:116-124.
24. Wang TL, Huang YH, Chang H. Somatostatin analogue mimics acute ischemic preconditioning in a rat model of myocardial infarction. J Cardiovasc Pharmacol. 2005;45: 327-332.
25. Schwarz ER, Reffelmann T, Kloner RA. Clinical effects of ischemic preconditioning. Curr Opin Cardiol. 1999;14: 340-348.
26. Zhang J, Ishibashi Y, Zhang Y, et al. Myocardial bioenergetics during acute hibernation. Am J Physiol. 1997;273:H1452-1463.
27. Malan A, Rodeau JL, Daull F. Intracellular pH in hibernation and respiratory acidosis in the European hamster. J Comp Physiol [B]. 1985;156:251-258.
28. Peart JN, Gross GJ. Exogenous activation of delta- and kappa-opioid receptors affords cardioprotection in isolated murine heart. Basic Res Cardiol. 2004;99:29-37.
29. Shi E, Jiang X, Bai H, et al. Cardioprotective effects of morphine on rat heart suffering from ischemia and reperfusion. Chin Med J (Engl). 2003;116:1059-1062.
30. Mayfield KP, D'Alecy LG. Role of endogenous opioid peptides in the acute adaptation to hypoxia. Brain Res. 1992;582:226-231.
31. Wu S, Wong MC, Chen M, et al. Role of opioid receptors in cardioprotection of cold-restraint stress and morphine. JBiomed Sci. 2004;11:726-731.
32. Schultz JEJ, Hsu AK, Gross GG. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res. 1996;78:1100-1104.
33. Barry U, Zuo Z. Opioids: old drugs for potential new applications. Current Pharmaceutical Design. 2005; 11:1343-1350.
34. Romano MA, Seymour EM, Berry JA, et al. Relative contribution of endogenous opioids to myocardial ischemic tolerance. J Surg Res. 2004;118:32-37.
35. Romano MA, McNish R, Seymour EM, et al. Differential effects of opioid peptides on myocardial ischemic tolerance. J Surg Res. 2004;119:46-50.
36. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem. 1998;186:3-12.
37. Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KAtp channels. Circ Res. 1999;84:1396-1400.
38. McPherson BC, Yao Z. Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. Anesthesiology. 2001;94:1082-1088.
39. Gonzalez-Cuello A, Milanes MV, Laorden ML. Increase of tyrosine hydroxylase levels and activity during morphine withdrawal in the heart. Eur J Pharmacol. 2004;506:119-128.
40. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: recent advances and future perspectives. Vasc Pharmacol. 2005;42:211-218. Epub 2005 Mar 17.
41. Takasaki Y, Wolff RA, Chien GL, et al. Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta-opioid receptors. Am J Physiol. 1999;277:H2442-450.
42. Withington DE, Decell MK, Al Ayed T. A case of propofol toxicity: further evidence for a causal mechanism. Paediatr Anaesth. 2004;14:505-508.
43. Wang TL, Chang H, Hung CR, et al. Attenuation of neutrophil and endothelial activation by intravenous morphine in patients with acute myocardial infarction. Am J Cardiol. 1997;80:1532-1535.
44. Wang TL, Chang H, Hung CR, et al. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction. Cardiovasc Res. 1998;40:557-563.
45. Lim YJ, Zheng S, Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology. 2004; 100:562-568.
46. Meine TJ. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005;149:1043-1049.
47. Markiewicz W Morphine increases myocardial infarction size in rats. Anesth Analg. 1982;61:843-846.
48. Sethna DH, Moffitt EA, Gray RJ, et al. Cardiovascular effects of morphine in patients with coronary arterial disease. Anesth Analg. 1982;61:109-114.
49. Alcaraz C, Bansinath M, Turndorf H, et al. Cardiovascular effects of morphine during hypothermia. Arch Int Pharmacodyn Ther. 1989;297:133-147.
50. Lechleitner P, Genser N, Mitterschiffthaler G, et al. Propofol for direct current cardioversion in cardiac risk patients. Eur Heart J. 1991;12:813-817.
51. Ozturk T, Cakan A, Gulerce G, et al. Sedation for fiberoptic bronchoscopy: fewer adverse cardiovascular effects with propofol than with midazolam. Anasthesiol Intensivmed Notfallmed Schmerzther. 2004;39:597-602.
52. Kanaya N, Hirata N, Kurosawa S, et al. Differential effects of propofol and sevoflurane on heart rate variability. Advances in Anesthesia. 1998;15:33-74.
53. Kanaya N, Hirata N, Kurosawa S, et al. Differential effects of propofol and sevoflurane on heart rate variability. Anesthesiology. 2003;98:34-40.
54. Angelini G, Ketzler JT, Coursin DB. Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit. Crit Care Clin. 2001;17:863-880.
55. Cauhepe C, Olivier M, Villaceque-Tribut A, et al. Propofol in emergency anesthesia. Can Anesthesiol. 1989;37:45-48.
56. Sochala C, Deenen D, Ville A, et al. Heart block following propofol in a child. Paediatr Anaesth. 1999;9:349-351.
57. Holzki J, Aring C, Gillor A. Death after re-exposure to propofol in a 3-year-old child: a case report. Paediatr Anaesth. 2004;14:265-270.
58. Vasile B, Rasulo F, Candiani A, et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29: 1417-1425.
59. Kang TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother. 2002;36:1453-1456.
60. Cannon ML, Glazier SS, Bauman LA. Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion. JNeurosurg. 2001;95:1053-1056.
61. Cremer OL, Moons KG, Bouman EA, et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117-118.
62. Culp KE, Augoustides JG, Ochroch AE, et al. Clinical management of cardiogenic shock associated with prolonged propofol infusion. Anesth Analg. 2004;99: 221-226.
63. Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Crit Care Med. 2000; 28:3071-3074.
64. Stelow EB, Johari VP, Smith SA, et al. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem. 2000;46: 577-581.
65. Inoue H, Ogawa K, Takano Y, et al. A case of coronary artery spasm during epidural anesthesia with continuous infusion of propofol. Masui. 2003;52:769-772.
66. Ko SH, Yu CW, Lee SK, et al. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth Analg. 1997;85:719-724.
67. Kokita N, Hara A, Abiko Y, et al. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg. 1998;86:252-258.
68. Yoo KY, Yang SY, Lee J, et al. Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs. Br J Anaesth. 1999;82:90-96.
69. Mathur S, Farhangkhgoee P, Karmazyn M. Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Anesthesiology. 1999;91: 1349-1360.
70. Javadov SA, Lim KH, Kerr PM, et al. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res. 2000;45:360-369.
71. Lischke V, Probst S, Behne M, et al. ST segment changes in the ECG. Anesthesia induction with propofol, etomidate or midazolam in patients with coronary heart disease. Anaesthesist. 1993;42:435-440.
72. De Hert SG. Study on the effects of six intravenous anesthetic agents on regional ventricular function in dogs (thiopental, etomidate, propofol, fentanyl, sufentanil, alfentanil). Acta Anaesthesiol Belg. 1991;42:3-39.
73. Lim KH, Halestrap AP, Angelini GD, et al. Propofol is cardioprotective in a clinically relevant model of normo-thermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med (Maywood). 2005;230:413-420.
74. Hug CC Jr, McLeskey CH, Nahrwold ML, et al. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg. 1993;77(Suppl):S21-29.
75. Pernerstorfer T, Mayer N, Jilma B, et al. Does phospho-diesterase III inhibition reverse the cardiodepressive effects of propofol? Anesth Analg. 1997;85:725-728.
76. Tzen CC, Tsai YJ, Chang CL. Cardiovascular responses to tracheal intubation after thiopentone or propofol. Ma Zui Xue Za Zhi. 1990;28:185-190.
77. Wahr JA, Plunkett JJ, Ramsay JG, et al. Cardiovascular responses during sedation after coronary revascularization. Incidence of myocardial ischemia and hemodynamic episodes with propofol versus midazolam. Institutions of the McSPI Research Group. Anesthesiology. 1996;84:1350-1360.
78. Williams GD, Jones TK, Hanson KA, et al. The hemodynamic effects of propofol in children with congenital heart disease. Anesth Analg. 1999;89:1411-1416.
79. Dingley J, King R, Hughes L, et al. Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery. Anaesthesia. 2001;56: 829-835.
80. Price ML, Millar B, Grounds M, et al. Changes in cardiac index and estimated systemic vascular resistance during induction of anaesthesia with thiopentone, methohexitone, propofol and etomidate. Br J Anaesth. 1992;69: 172-176.
81. Haessler R, Madler C, Klasing S, et al. Propofol/fentanyl versus etomidate/fentanyl for the induction of anesthesia in patients with aortic insufficiency and coronary artery disease. J Cardiothorac Vasc Anesth. 1992;6:173-180.
82. Pensado A, Molins N, Alvarez J. Cardiovascular effects of a single dose of propofol in coronary patients with good ventricular function. Rev Esp Anestesiol Reanim. 1994;41:147-151.
83. Muzi M, Berens RA, Kampine JP, et al. Venodilation contributes to propofol-mediated hypotension in humans. Anesth Analg. 1992;74:877-883.
84. Ozaki M. The effects of propofol and midazolam on canine left ventricular contractility. Masui. 2002;51:611-619.
85. Hall RI, MacLaren C, Smith MS, et al. Light versus heavy sedation after cardiac surgery: myocardial ischemia and the stress response. Maritime Heart Centre and Dalhousie University. Anesth Analg. 1997;85:971-978.
86. Suzer O, Suzer A, Aykac Z, et al. Direct cardiac effects in isolated perfused rat hearts measured at increasing concentrations of morphine, alfentanil, fentanyl, ketamine, etomidate, thiopentone, midazolam and propofol. Eur J Anaesthesiol. 1998;15:480-485.
87. Grounds RM, Morgan M, Lumley J. Some studies on the properties of the intravenous anaesthetic, propofol ('Diprivan')-a review. Postgrad Med J. 1985;61(Suppl 3): 90-95.
88. Fanton JW, Zarr SR, Ewert DL, et al. Cardiovascular responses to propofol and etomidate in long-term instrumented rhesus monkeys (Macaca mulatta). Comp Med. 2000;50:303-308.
89. Ma D, Chakrabarti MK, Whitwam JG. Propofol, bradycardia and the Bezold-Jarisch reflex in rabbits. Br J Anaesth. 1999;82:412-417.
90. Ma D, Chakrabarti MK, Whitwam JG. Propofol, bradycardia and the Bezold-Jarisch reflex in rabbits. Br J Anaesth. 1999;82:412-417.
91. Pires LA, Huang SK, Wagshal AB, et al. Electrophysiological effects of propofol on the normal cardiac conduction system. Cardiology. 1996;87:319-324.
92. Cullen PM, Turtle M, Prys-Roberts C, et al. Effect of propofol anesthesia on baroreflex activity in humans. Anesth Analg. 1987;66:1115-1120.
93. Trekova NA, Iavorovskii AG, Flerov EV, et al. The effect of current methods of induction anesthesia on the systolic and diastolic functions of the left and right heart in patients with ischemic heart disease. Anesteziol Reanimatol. 1999;5:4-9.
94. Gelissen HP, Epema AH, Henning RH, et al. Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology. 1996;84:397-403.
95. Stowe DF, Bosnjak ZJ, Kampine JP. Comparison of etomidate, ketamine, midazolam, propofol, and thiopental on function and metabolism of isolated hearts. Anesth Analg. 1992;74:547-558.
96. Buljubasic N, Marijic J, Berczi V, et al. Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells. Anesthesiology. 1996;85:1092-1099.
97. Brussel T, Theissen JL, Vigfusson G, et al. Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol. Anesth Analg. 1989;69:35-40.
98. Hebbar L, Dorman BH, Clair MJ, et al. Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure. Anesthesiology. 1997;86:649-659.
99. Pernerstorfer T, Mayer N, Jilma B, et al. Does phospho-diesterase III inhibition reverse the cardiodepressive effects of propofol? Anesth Analg. 1997;85:725-728.
100. Hullander RM, Leivers D, Wingler K. A comparison of propofol and etomidate for cardioversion. Anesth Analg. 1993;77:690-694.
101. Ikeno S, Akazawa S, Shimizu R, et al. Propofol does not affect the canine cardiac conduction system under autonomic blockade. Can J Anaesth. 1999;46:148-153.
102. Whyte SD, Booker PD, Buckley DG. The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children. Anesth Analg. 2005;100:71-77.
103. Paventi S, Santevecchi A, Ranieri R. Effects of sevoflurane versus propofol on QT interval. Minerva Anestesiol. 2001;67:637-640.
104. Elhairy A, Seguier JC, Sinda P. Auriculo-ventricular conduction disorder following a continuous administration of propofol. Apropos of a case. Can Anesthesiol. 1992; 40:417-419.
105. Vabishchevich AV, Meshcheriakov AV, Kochneva ZV, et al. Experience in the clinical use of intravenous hypnotic pofol (propofol) in anesthesias of different duration. Anesteziol Reanimatol. 2001;3:13-16.
106. Mohler H, Richards JG. The benzodiazepine receptor: a pharmacological control element of brain function. Eur J Anaesthesiol Suppl. 1988;2:15-24.
107. Kamijo Y, Masuda T, Nishikawa T, et al. Cardiovascular response and stress reaction to flumazenil injection in patients under infusion with midazolam. Crit Care Med. 2000;28:318-323.
108. Biswas AK, Feldman BL, Davis DH, et al. Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal. Clin Toxicol (Phila). 2005;43:207-209.
109. Liang SW. Studies of midazolam, diazepam and thiopentone on respiratory and cardiovascular function during induction anesthesia. Zhonghua Wai Ke Za Zhi. 1991;29:161-164, 205.
110. Jones DJ, Stehling LC, Zauder HL. Cardiovascular responses to diazepam and midazolam maleate in the dog. Anesthesiology. 1979;51:430-434.
111. Patel IH, Soni PP, Fukuda EK, et al. The pharmacokinetics of midazolam in patients with congestive heart failure. Br J Clin Pharmacol. 1990;29:565-569.
112. Agelink MW, Majewski TB, Andrich J, et al. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med. 2002;30:997-1006.
113. Berntson GG, Hart S, Ruland S, et al. A central cholinergic link in the cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142. Behav Brain Res. 1996;74:91-103.
114. Yazawa K, Adachi W, Owa M, et al. Can sedation reduce the cardiac stress during gastrointestinal endoscopy? A study with non-invasive automated cardiac flow measurement by color Doppler echocardiography. Scand J Gastroenterol. 2002;37:602-607.
115. Ristikankare M, Julkunen R, Laitinen T, et al. Effect of conscious sedation on cardiac autonomic regulation during colonoscopy. Scand J Gastroenterol. 2000;35: 990-996.
116. Hilfiker O, Larsen R, Stafforst D, et al. The effects of midazolam on the general, coronary and cerebral circulation. Anaesthesist. 1980;29:337-338.
117. Hanaoka K, Namiki A, Dohi S, et al. A dose-ranging study of midazolam for postoperative sedation of patients: a randomized, double-blind, placebo-controlled trial. Crit Care Med. 2002;30:1256-1260.
118. Raza SM, Zsigmond EK, Barabas E. Midazolam causes no adverse hemodynamic effects in cardiac patients. Clin Ther. 1987;10:40-43. (Pubitemid 18085041)
119. Raza SM, Masters RW, Zsigmond EK. Comparison of the hemodynamic effects of midazolam and diazepam in patients with coronary occlusion. Int J Clin Pharmacol Ther Toxicol. 1989;27:1-6.
120. Reitan JA, Soliman IE. A comparison of midazolam and diazepam for induction of anaesthesia in high-risk patients. Anaesth Intensive Care. 1987;15:175-178.
121. Massaut J, d'Hollander A, Barvais L, et al. Haemodynamic effects of midazolam in the anaesthetized patient with coronary artery disease. Acta Anaesthesiol Scand. 1983;27:299-302.
122. Hilfiker O, Larsen R, Stafforst D, et al. The effects of midazolam on the general, coronary and cerebral circulation. Anaesthesist. 1980;29:337-338.
123. Szekely A, Heindl B, Zahler S, et al. Nonuniform behavior of intravenous anesthetics on postischemic adhesion of neutrophils in the guinea pig heart. Anesth Analg. 2000;90:1293-1300.
124. Gologorskii VA, Gel'fand BR, Grinenko TF, et al. Clinical experience in the use of dormicum (midazolam) in anesthesiology and intensive care. Anesteziol Reanimatol. 1994;6:9-12.
125. Shekerdemian L, Bush A, Redington A. Cardiovascular effects of intravenous midazolam after open heart surgery. Arch Dis Child. 1997;76:57-61.
126. Klockgether-Radke AP, Thudium A, Frerichs A, et al. High-dose midazolam and the attenuation of the contractile response to vasoconstrictors in coronary artery segments. Eur J Anaesthesiol. 2003;20:289-293. (Pubitemid 36433382)
127. Lopez Soriano F, Rivas Lopez FA, Crespo Toral J, et al. Cardiovascular response to orotracheal intubation using midazolam or etomidate in anesthesia induction. Rev Esp Anestesiol Reanim. 1991;38:170-172.
128. MacGillivray RG, Rocke DA, Mahomedy AE. Midazolam for induction of anaesthesia in patients with limited cardiac reserves. A comparison with etomidate. S Afr Med J. 1988;73:101-103.
129. Nakae Y, Kanaya N, Namiki A. The direct effects of diazepam and midazolam on myocardial depression in cultured rat ventricular myocytes. Anesth Analg. 1997;85: 729-733.
130. Nonaka A, Kashimoto S, Imamura M, et al. Mechanism of the negative inotropic effect of midazolam and diazepam in cultured foetal mouse cardiac myocytes. Eur J Anaesthesiol. 1997;14:481-487.
131. Oguchi T, Kashimoto S, Yamaguchi T, et al. Effects of intravenous anesthetics on function and metabolism in the reperfused working rat heart. Jpn J Pharmacol. 1995; 68:413-421.
132. Medlin RP Jr, Ransom MM, Watts JA, et al. Effect of ethanol, haloperidol, and lorazepam on cardiac conduction and contraction. J Cardiovasc Pharmacol. 1996;28: 792-798.
133. Yip AS, McGuire MA, Davis L, et al. Lack of effect of midazolam on inducibility of arrhythmias at electro-physiologic study. Am J Car diol. 1992;70:593-597.
134. Yip AS, McGuire MA, Davis L, et al. Lack of effect of midazolam on inducibility of arrhythmias at electro-physiologic study. Am J Cardiol. 1992;70:593-597.
135. Kanaya N, Murray PA, Damron DS. The differential effects of midazolam and diazepam on intracellular Ca2+ transients and contraction in adult rat ventricular myocytes. Anesth Analg. 2002;95:1637-1644.
136. Bennett AJ, DePetrillo PB. Differential effects of MK801 and lorazepam on heart rate variability in adolescent rhesus monkeys. J Cardiovasc Pharmacol. 2005;45:383-388.
137. Honderick T, Williams D, Seaberg D, et al. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Am J Emerg Med. 2003;21:39-42.
138. Vogel LR, Muskin PR, Collins ED, et al. Lorazepam reduces cardiac vagal modulation in normal subjects. J Clin Psychopharmacol. 1996;16:449-453.
139. van den Berg F, Tulen JH, Boomsma F, et al. Effects of alprazolam and lorazepam on catecholaminergic and cardiovascular activity during supine rest, mental load and orthostatic challenge. Psychopharmacology (Berl). 1996;128:21-30.
140. Tulen JH, Mulder G, Pepplinkhuizen L, et al. Effects of lorazepam on cardiac vagal tone during rest and mental stress: assessment by means of spectral analysis. Psychopharmacology (Berl). 1994;114:81-89.
141. Cernaianu AC, DelRossi AJ, Flum DR, et al. Lorazepam and midazolam in the intensive care unit: A randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost. Crit Care Med. 1996;24: 222-228.
142. Harvey AT, Flockhart D, Gorski JC, et al. Intramuscular haloperidol or lorazepam and QT intervals in schizophrenia. J Clin Pharmacol. 2004;44:1173-1184.
143. Trekova NA, Iavorovskii AG, Flerov EV, et al. The effect of current methods of induction anesthesia on the systolic and diastolic functions of the left and right heart in patients with ischemic heart disease. Anesteziol Reanimatol. 1999;5:4-9.
144. Cote P, Campeau L, Bourassa MG. Therapeutic implications of diazepam in patients with elevated left ventricular filling pressure. Am Heart J. 1976;91:747-751.
145. Allen GD, Everett GB, Butler LA. Human cardiorespiratory and analgesic effects of intravenous diazepam and local anesthesia. J Am Dent Assoc. 1976;92:744-747.
146. Cote P, Noble J, Bourassa MG. Systemic vasodilatation following diazepam after combined sympathetic and parasympathetic blockade in patients with coronary heart disease. Cathet Cardiovasc Diagn. 1976;2:369-380.
147. Daniell HB. Cardiovascular effects of diazepam and chlordiazepoxide. Eur J Pharmacol. 1975;32:58-65.
148. Ujfalusi A, Cseppento A, Antal K, et al. The effect of chronic diazepam treatment on hypoxia-induced alterations in functional activity of guinea pig myocardium. Acta Physiol Hung. 1996;84:345-346.
149. Marin J, Hernandez J. Diazepam potentiates the effects of endogenous catecholamines on contractility and cyclic AMP levels in rat ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:260-268. Epub 2002 Mar 1.
150. Hara Y, Chugun A, Futamura K, et al. Diazepam increases calcium sensitivity of the skinned cardiac muscle fiber in guinea pig. Jpn J Pharmacol. 1999;81:122-124.
151. Gijon E, Garcia X, Marquez-Orozco MC, Marquez-Orozco A. Ca2+-agonistic effects of diazepam, a benzo-diazepine 1-4 derivative, on isolated mouse and guinea pig left atria. P R Health Sci J. 1988;7:199-202.
152. Hara Y, Kaigo H, Minami I, et al. Diazepam potentiates the positive inotropic effects of histamine and forskolin in guinea-pig papillary muscles. J Vet Pharmacol Ther. 1998;21:375-379.
153. Martinez E, Penafiel R, Collado MC, et al. Diazepam potentiates the positive inotropic effect of isoprenaline in rat ventricle strips: role of cyclic AMP. Eur J Pharmacol. 1995;282:169-175.
154. Mailliet F, Galloux P, Poisson D. Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in Wistar rats. Psychopharmacology (Berl). 2001;156:417-426.
155. Castro JL, Ricci D, Taira CA, et al. Central benzodiaz-epine involvement in clonidine cardiovascular actions. Can J Physiol Pharmacol. 1999;77:844-851.
156. Hara Y, Kobayashi H, Ooshiro S, et al. Negative inotropic effect of diazepam in isolated guinea pig heart. J Vet Med Sci. 2001;63:135-143.
157. Riou B, Lecarpentier Y, Barriot P, et al. Diazepam does not improve the mechanical performance of rat cardiac papillary muscle exposed to chloroquine in vitro. Intensive Care Med. 1989;15:390-395.
158. Le Fur G, Mestre M, Carriot T, et al. Pharmacology of peripheral type benzodiazepine receptors in the heart. Prog Clin Biol Res. 1985;192:175-186.
159. Zeegers A, van Wilgenburg H, Leeuwin RS. Cardiac effects of benzodiazepine receptor agonists and antagonists in the isolated rat heart: a comparative study. Life Sci. 1998;63:1439-1456.
160. Hernandez J. The negative inotropic effect of diazepam in rat right ventricular strips. J Pharm Pharmacol. 1991;43: 879-881.
161. Leeuwin RS, Zeegers A, Van Wilgenburg H. PK 11195 antagonizes the positive inotropic response of the isolated rat heart to diazepam but not the negative inotropic response. Eur J Pharmacol. 1996;299:149-152. (Pubitemid 26104652)
162. Leeuwin RS, Zeegers A, van Wilgenburg H. Actions of benzodiazepines on the inotropy of the perfused rat heart. Arch Int Pharmacodyn Ther. 1993;326:5-12.
163. French JF, Rapoport RM, Matlib MA. Possible mechanism of benzodiazepine-induced relaxation of vascular smooth muscle. J Cardiovasc Pharmacol. 1989;14:405-411.
164. Jacob MK, White RE. Diazepam, gamma-aminobutyric acid, and progesterone open K(+) channels in myocytes from coronary arteries. Eur J Pharmacol. 2000;403:209-219.
165. Ujfalusi A, Cseppento A, Nagy E, et al. Sensitization by chronic diazepam treatment of A2A adenosine receptor-mediated relaxation in rat pulmonary artery. Life Sci. 1999;64:PL19-25.
166. Ishii K, Kano T, Ando J. Pharmacological effects of flurazepam and diazepam on isolated canine arteries. Jpn J Pharmacol. 1983;33:65-71.
167. Jacka MJ, Johnson GD, Milne B. Diazepam's effect on systemic vascular resistance during cardiopulmonary bypass is not caused by its vehicle (alcohol-propylene glycol). J Cardiothorac Vasc Anesth. 1993;7:28-29.
168. Barron KW, Pavelka SM, Garrett KM. Diazepam-sensitive GABA(A) receptors in the NTS participate in cardiovascular control. Brain Res. 1997;773:53-60.
169. Zackova P, Kvetina J, Nemec J, et al. Cardiovascular effects of diazepam and nitrazepam in combination with ethanol. Pharmazie. 1982;37:853-856.
170. Hempelmann G, Seitz W, Piepenbrock S. Diazepam (valium). Changes in haemodynamics, myocardial oxygen consumption and vascular tone. Anaesthesist. 1978; 27:357-363.
171. Clarke RS, Lyons SM. Diazepam and flunitrazepam as induction agents for cardiac surgical operations. Acta Anaesthesiol Scand. 1977;21:282-292.
172. Enero MA, Solignac D, Apud JA. Studies on the GABAergic system in cardiovascular control in normotensive and in sinoaortic denervated rats. Clin Exp Hypertens A. 1988;10(Suppl 1):331-337.
173. Haskins SC, Farver TB, Patz JD. Cardiovascular changes in dogs given diazepam and diazepam-ketamine. Am J Vet Res. 1986;47:795-798.
174. Rozonov IuB. Cardiovascular effects of diazepam and chlordiazepoxide in experiments on non-narcotized animals. Farmakol Toksikol. 1976;39:163-167.
175. Muir WW, Werner LL, Hamlin RL. Antiarrhythmic effects of diazepam during coronary artery occlusion in dogs. Am J Vet Res. 1975;36:1203-1206.
176. Dahlgren G, Settergren G, Ribeiro A, et al. Changes in left ventricular diameter during intravenous induction of anesthesia. J Cardiothorac Vasc Anesth. 1993;7:399-401.
177. Kumagai K, Yamanouchi Y, Matsuo K, et al. Antiarrhythmic and proarrhythmic properties of diazepam demonstrated by electrophysiological study in humans. Clin Cardiol. 1991;14:397-401.
178. Ruiz F, Hernandez J, Perez D. The effect of diazepam on atrial automaticity is not mediated by benzodiazepine receptors. Arch Int Pharmacodyn Ther. 1989;299:77-85.
179. Ruiz F, Hernandez J, Perez D. The effect of diazepam on ventricular automaticity induced by a local injury. Evidence of involvement of 'peripheral type' benzodiazepine receptors. J Pharm Pharmacol. 1989;41:306-310.
180. Nakajima T, Kaneshiro S, Yatabe Y, et al. Negative dromotropic effect of diazepam on the AV node of dog heart in situ. Arch Int Pharmacodyn Ther. 1979;241: 153-164.
181. Dunsworth AR, Thornton WE, Byrd DL, et al. Evaluation of cardiovascular and pulmonary changes during meperidine-diazepam anesthesia. J Oral Surg. 1975;33: 18-22.
182. Yang CP, Chou LS, Liu HJ, et al. Diazepam facilitates reflex bradycardia in conscious rats. J Pharm Pharmacol. 1987;39:1034-1036.
183. Acosta D, Chappell R. Cardiotoxicity of diazepam in cultured heart cells. Toxicology. 1977;8:311-317.
184. Berry DG. Effects of diazepam on the isolated chick embryo heart. Proc Soc Exp Biol Med. 1975;150:240-243.
185. Ristic V, Tepsic V, De Luka SR, et al. Phospholipid content and fatty acid composition in the rat heart after chronic diazepam treatment. Physiol Res. 1998;47:115-118. (Pubitemid 28281093)
186. Oglesby AJ. Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department? Emerg Med J. 2004;21:655-659.
187. Xu JS, Chen HX, Chen H, et al. Effect of etomidate on hemodynamics in elderly and shock patients during general anesthesia induction. Di Yi Jun Yi Da Xue Xue Bao. 2005;25:1060-1061.
188. Pascoe PJ, Ilkiw JE, Haskins SC, et al. Cardiopulmonary effects of
189. Mazerolles M, Senard JM, Verwaerde P, et al. Effects of pentobarbital and etomidate on plasma catecholamine levels and spectral analysis of blood pressure and heart rate in dogs. Fundam Clin Pharmacol. 1996;10:298-303. (Pubitemid 26228380)
190. Sun DJ. Hemodynamic effects of etomidate in cardiac surgery during induction of anesthesia. Zhonghua Wai Ke Za Zhi. 1991;29:682-684, 718.
191. Lindeburg T, Spotoft H, Bredgaard Sorensen M, et al. Cardiovascular effects of etomidate used for induction and in combination with fentanyl-pancuronium for maintenance of anaesthesia in patients with valvular heart disease. Acta Anaesthesiol Scand. 1982;26:205-208.
192. Hoffmann P, Schockenhoff B. The influence on the cardiovascular system of etomidate infusion anaesthesia combined with fentanyl/nitrous oxide. Anasth Inten-sivther Notfallmed. 1981;16:323-326.
193. Tsutsumi Y, Oshita S, Kitahata H, et al. Blockade of adenosine triphosphate-sensitive potassium channels by thiamylal in rat ventricular myocytes. Anesthesiology. 2000;92:1154-1159.
194. Gooding JM, Corssen G. Effect of etomidate on the cardiovascular system. Anesth Analg. 1977;56:717-719.
195. Patschke D, Bruckner JB, Gethmann JW, et al. Comparison of the immediate effects of etomidate, propanidid and thiopentone on haemodynamics, coronary blood-flow and myocardial oxygen consumption. Acta Anaesthesiol Belg. 1975;26:112-119.
196. Safran D, Pelouze G, Roujas F. Hemodynamic effects of etomidate. Ann Anesthesiol Fr. 1978;19:214-218.
197. Paris A, Philipp M, Tonner PH, et al. Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Anesthesiology. 2003;99:889-895.
198. Guldner G, Schultz J, Sexton P, et al. Etomidate for rapid-sequence intubation in young children: hemodynamic effects and adverse events. Acad Emerg Med. 2003; 10:134-139.
199. Batjer HH. Cerebral protective effects of etomidate: experimental and clinical aspects. Cerebrovasc Brain Metab Rev. 1993;5:17-32.
200. Sprung J, Ogletree-Hughes ML, Moravec CS. The effects of etomidate on the contractility of failing and nonfailing human heart muscle. Anesth Analg. 2000;91:68-75.
201. Mattheussen M, Housmans PR. Mechanism of the direct, negative inotropic effect of etomidate in isolated ferret ventricular myocardium. Anesthesiology. 1993;79:1284-1295.
202. Sfez M, Le Mapihan Y, Gaillard JL, et al. Hemodynamic effects of etomidate in the child: a study of the dose-effect relation. Can Anesthesiol. 1989;37:155-159.
203. Komai H, DeWitt DE, Rusy BF. Negative inotropic effect of etomidate in rabbit papillary muscle. Anesth Analg. 1985;64:400-404.
204. Kissin I, Motomura S, Aultman DF, et al. Inotropic and anesthetic potencies of etomidate and thiopental in dogs. Anesth Analg. 1983;62:961-965.
205. Rifat K, Gamulin Z, Gemperle M. Etomidate: cardiovascular effects of a new intravenous anesthetic agent. Can Anaesth Soc J. 1976;23:492-504.
206. Lamalle D. Cardiovascular effects of various anesthetics in man. Four short-acting intravenous anesthetics: althesin, etomidate, methohexital and propanidid. Acta Anaesthesiol Belg. 1976;27(Suppl):208-224.
207. Criado A, Maseda J, Navarro E, et al. Induction of anaesthesia with etomidate: haemodynamic study of 36 patients. Br J Anaesth. 1980;52:803-806. (Pubitemid 10090449)
208. Colvin MP, Savege TM, Newland PE, et al. Cardiorespiratory changes following induction of anaesthesia with etomidate in patients with cardiac disease. Br J Anaesth. 1979;51:551-556.
209. Hempelmann G, Seitz W, Piepenbrock S. Combination of etomidate and fentanyl. Haemodynamics, inotropic state, myocardial oxygen consumption, and vascular reactions. Anaesthesist. 1977;26:231-238.
210. Patschke D, Bruckner JB, Eberlein HJ, et al. Effects of althesin, etomidate and fentanyl on haemodynamics and myocardial oxygen consumption in man. Can Anaesth Soc J. 1977;24:57-69.
211. Singbartl G, Langrehr D, Neuhaus R. Cardiodepressive effects due to ketamine, etomidate, methohexitone and propanidid. A clinical study by means of the systolic-time-intervals. Prakt Anaesth. 1976;11:397-404.
212. Riou B, Lecarpentier Y, Viars P. Effects of etomidate on the cardiac papillary muscle of normal hamsters and those with cardiomyopathy. Anesthesiology. 1993;78: 83-90.
213. De Hert SG, Vermeyen KM, Adriaensen HF. Influence of thiopental, etomidate, and propofol on regional myocardial function in the normal and acute ischemic heart segment in dogs. Anesth Analg. 1990;70:600-607.
214. Prakash O, Dhasmana KM, Verdouw PD, et al. Cardiovascular effects of etomidate with emphasis on regional myocardial blood flow and performance. Br J Anaesth. 1981;53:591-599.
215. Gooding JM, Weng JT, Smith RA, et al. Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg. 1979;58:40-41.
216. Van den Hurk AW, Teijen HJ. Cardiac complications during use of etomidate. Anaesthesia. 1983;38:1183-1184.
217. Pagel PS, Hettrick DA, Kersten JR, et al. Etomidate adversely alters determinants of left ventricular afterload in dogs with dilated cardiomyopathy. Anesth Analg. 1998;86:932-938.
218. Larsen R, Rathgeber J, Bagdahn A, et al. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients. A comparison with etomidate. Anaesthesia. 1988;43(Suppl):25-31.
219. Stockham RJ, Stanley TH, Pace NL, et al. Induction of anesthesia with fentanyl or fentanyl plus etomidate in high-risk patients. J Cardiothorac Anesth. 1987;1:19-23.
220. Harris CE, Murray AM, Anderson JM, et al. Effects of thiopentone, etomidate and propofol on the haemodynamic response to tracheal intubation. Anaesthesia. 1988; 43(Suppl):32-36.
221. Pfeifer G, Tauberger G, Schulte am Esch J. An experimental study of the effect of etomidate on central sympathetic activity, respiration and circulation. Prakt Anaesth. 1978;13:495-501.
222. Hughes RL, MacKenzie JE. An investigation of the centrally and peripherally mediated cardiovascular effects of etomidate in the rabbit. Br J Anaesth. 1978;50: 101-108.